VACINAS:: PROGRESSOS E NOVOS DESAFIOS PARA O CONTROLE DE DOENÇAS IMUNOPREVENÍVEIS

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-09-01

• Fields of study

  Biology, Political Science, Medicine, Environmental Science

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Know Your Enemy:

  2020cited by this paper
• Pasado, presente y futuro de la vacunación anti-idiotipo

  2017cited by this paper
• Know your enemy

  2014cited by this paper
• Idiotype vaccines for lymphoma therapy

  2011cited by this paper
• Commentary on "Sipuleucel-T immunotherapy for castration-resistant prostate cancer". Kantoff PW, Higano CS, Shore ND, Berger

  2011cited by this paper
• Strategies for Cancer Vaccine Development

  2010cited by this paper
• Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

  2010cited by this paper
• Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures

  2009cited by this paper
• Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

  2008cited by this paper
• Vacunas derivadas del análisis de los genomas: vacunología inversa

  2008cited by this paper
• Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice.

  2007cited by this paper
• Cancer vaccines: preclinical studies and novel strategies.

  2006cited by this paper
• Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015.

  2006cited by this paper
• Immunogenicity in humans of an edible vaccine for hepatitis B.

  2005cited by this paper
• Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoediting.

  2005cited by this paper
• Humoral immune response in prostate cancer patients after immunization with gene-based vaccines that encode for a protein that is proteasomally degraded.

  2005cited by this paper
• Plants as bioreactors for protein production: avoiding the problem of transgene silencing

  2004cited by this paper
• Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

  2004cited by this paper
• Intranasal Vaccination against Cutaneous Leishmaniasis with a Particulated Leishmanial Antigen or DNA Encoding LACK

  2004cited by this paper
• From Pasteur to genomics: progress and challenges in infectious diseases

  2004cited by this paper
• The cause of the plague of Athens: plague, typhoid, typhus, smallpox, or measles?

  2004cited by this paper
• Novas perspectivas em vacinas virais

  2003cited by this paper
• Benjamin Jesty: new light in the dawn of vaccination.

  2003cited by this paper
• Microparticles and nanoparticles as delivery systems for DNA vaccines.

  2003cited by this paper
• Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.

  2003cited by this paper
• Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.

  2003cited by this paper
• Top ten biotechnologies for improving health in developing countries

  2002cited by this paper
• Recent developments in vaccine delivery systems.

  2001cited by this paper
• Chitosan as a novel nasal delivery system for vaccines.

  2001cited by this paper
• Chitosan for mucosal vaccination.

  2001cited by this paper
• Toll-like receptors and innate immunity

  2001cited by this paper
• Transgenic plants as factories for biopharmaceuticals

  2000cited by this paper
• Vaccines for mucosal immunity to combat emerging infectious diseases.

  2000cited by this paper
• Reverse vaccinology.

  2000cited by this paper
• DNA vaccines: immunology, application, and optimization*.

  2000cited by this paper
• Genetic vaccines.

  1999cited by this paper
• The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered.

  1998cited by this paper
• CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

  1996cited by this paper
• Heat stability of a recombinant DNA hepatitis B vaccine.

  1992cited by this paper
• Expression of hepatitis B surface antigen in transgenic plants.

  1992cited by this paper
• Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats.

  1992cited by this paper

• Imunocards: aprendendo as defesas do organismo jogando

  2022cites this paper
• Knowledge Creation on Edible Vaccines

  2020cites this paper